annual cash & cash equivalents:
$435.45M+$313.82M(+258.02%)Summary
- As of today (June 22, 2025), DYN annual cash & cash equivalents is $435.45 million, with the most recent change of +$313.82 million (+258.02%) on December 31, 2024.
- During the last 3 years, DYN annual cash & cash equivalents has risen by +$234.62 million (+116.83%).
- DYN annual cash & cash equivalents is now at all-time high.
Performance
DYN Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$472.25M+$36.81M(+8.45%)Summary
- As of today (June 22, 2025), DYN quarterly cash & cash equivalents is $472.25 million, with the most recent change of +$36.81 million (+8.45%) on March 31, 2025.
- Over the past year, DYN quarterly cash & cash equivalents has increased by +$200.22 million (+73.60%).
- DYN quarterly cash & cash equivalents is now -22.35% below its all-time high of $608.20 million, reached on June 30, 2024.
Performance
DYN quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
DYN Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +258.0% | +73.6% |
| 3 y3 years | +116.8% | +219.2% |
| 5 y5 years | +2876.0% | - |
DYN Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +258.0% | -22.4% | +288.3% |
| 5 y | 5-year | at high | +2876.0% | -22.4% | +288.3% |
| alltime | all time | at high | +5260.0% | -22.4% | +3127.6% |
DYN Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $472.25M(+8.5%) |
| Dec 2024 | $435.45M(+258.0%) | $435.45M(-18.2%) |
| Sep 2024 | - | $532.16M(-12.5%) |
| Jun 2024 | - | $608.20M(+123.6%) |
| Mar 2024 | - | $272.04M(+123.7%) |
| Dec 2023 | $121.63M(-29.3%) | $121.63M(-6.6%) |
| Sep 2023 | - | $130.28M(-22.3%) |
| Jun 2023 | - | $167.61M(-7.5%) |
| Mar 2023 | - | $181.11M(+5.2%) |
| Dec 2022 | $172.15M | $172.15M(+18.8%) |
| Sep 2022 | - | $144.90M(+6.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $135.98M(-8.1%) |
| Mar 2022 | - | $147.97M(-26.3%) |
| Dec 2021 | $200.82M(-33.2%) | $200.82M(-12.3%) |
| Sep 2021 | - | $229.04M(-11.4%) |
| Jun 2021 | - | $258.38M(-16.9%) |
| Mar 2021 | - | $310.95M(+3.4%) |
| Dec 2020 | $300.85M(+1956.1%) | $300.85M(-20.7%) |
| Sep 2020 | - | $379.61M(+162.0%) |
| Jun 2020 | - | $144.87M(+890.1%) |
| Dec 2019 | $14.63M(+80.1%) | $14.63M |
| Dec 2018 | $8.12M | - |
FAQ
- What is Dyne Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Dyne Therapeutics?
- What is Dyne Therapeutics annual cash & cash equivalents year-on-year change?
- What is Dyne Therapeutics quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Dyne Therapeutics?
- What is Dyne Therapeutics quarterly cash & cash equivalents year-on-year change?
What is Dyne Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of DYN is $435.45M
What is the all time high annual cash & cash equivalents for Dyne Therapeutics?
Dyne Therapeutics all-time high annual cash & cash equivalents is $435.45M
What is Dyne Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, DYN annual cash & cash equivalents has changed by +$313.82M (+258.02%)
What is Dyne Therapeutics quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of DYN is $472.25M
What is the all time high quarterly cash & cash equivalents for Dyne Therapeutics?
Dyne Therapeutics all-time high quarterly cash & cash equivalents is $608.20M
What is Dyne Therapeutics quarterly cash & cash equivalents year-on-year change?
Over the past year, DYN quarterly cash & cash equivalents has changed by +$200.22M (+73.60%)